USPTO serial 99861659
Reviewed by CopyMark Law Group
Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose. Watch for publication (status 686) and monitor the 30-day opposition window.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Durham, NC, US
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ani Agrawal
Ani Agrawal NK Patent Law4101 Lake Boone TrailSTE 218Raleigh, NC 27607| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable mobile software application for clinical trial data collection and management; Downloadable software enabling clinical trial participants and research staff to submit health metrics, biospecimen data, survey responses, and treatment adherence information from mobile devices; Downloadable software providing secure, encrypted data transfer compliant with regulatory standards for use in the field of clinical trials; Downloadable software featuring data validation and monitoring, participant engagement tools such as notifications and reminders, and integration with electronic data capture (EDC) and laboratory information management systems (LIMS) for use in the field of clinical trials; Downloadable software user engagement tools, namely, reminders, notifications, and messaging systems to promote participant adherence and engagement for use in the field of clinical trials | ACTIVE | — |
| 042 | Software as a Service (SaaS) featuring a mobile platform for capturing, managing, and analyzing participant data in clinical trials; Providing temporary use of non-downloadable cloud-based software enabling clinical trial participants to input health metrics, complete digital surveys, and track treatment adherence; SaaS services offering tools for data collection, remote monitoring, data validation, and secure data management accessible to research teams through secure cloud-based infrastructure; Software as a Service (SaaS) featuring software for ensuring compliance with regulatory standards governing electronic records and digital signatures, featuring encryption, authentication, and access control for use in the field of clinical trials; Providing temporary use of online, non-downloadable software featuring user engagement tools, namely, reminders, notifications, and messaging systems to promote participant adherence and engagement for use in the field of clinical trials; Software as a Service (SaaS) featuring software that provides integration services with electronic data capture (EDC), laboratory information management systems (LIMS), and clinical trial management systems for streamlined clinical data management for use in the field of clinical trials; Providing temporary use of online, non-downloadable software enabling clinical trial participants and research staff to submit health metrics, biospecimen data, survey responses, and treatment adherence information from mobile devices; Providing temporary use of online, non-downloadable software featuring secure, encrypted data transfer compliant with regulatory standards for use in the field of clinical trials | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 7, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 7, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 6, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 3, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 3, 2026 | NWAP | NEW APPLICATION ENTERED | — |